242 related articles for article (PubMed ID: 22645303)
1. Claudin-2 promotes breast cancer liver metastasis by facilitating tumor cell interactions with hepatocytes.
Tabariès S; Dupuy F; Dong Z; Monast A; Annis MG; Spicer J; Ferri LE; Omeroglu A; Basik M; Amir E; Clemons M; Siegel PM
Mol Cell Biol; 2012 Aug; 32(15):2979-91. PubMed ID: 22645303
[TBL] [Abstract][Full Text] [Related]
2. Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes.
Tabariès S; Dong Z; Annis MG; Omeroglu A; Pepin F; Ouellet V; Russo C; Hassanain M; Metrakos P; Diaz Z; Basik M; Bertos N; Park M; Guettier C; Adam R; Hallett M; Siegel PM
Oncogene; 2011 Mar; 30(11):1318-28. PubMed ID: 21076473
[TBL] [Abstract][Full Text] [Related]
3. Lyn modulates Claudin-2 expression and is a therapeutic target for breast cancer liver metastasis.
Tabariès S; Annis MG; Hsu BE; Tam CE; Savage P; Park M; Siegel PM
Oncotarget; 2015 Apr; 6(11):9476-87. PubMed ID: 25823815
[TBL] [Abstract][Full Text] [Related]
4. Claudin-2 promotes colorectal cancer liver metastasis and is a biomarker of the replacement type growth pattern.
Tabariès S; Annis MG; Lazaris A; Petrillo SK; Huxham J; Abdellatif A; Palmieri V; Chabot J; Johnson RM; Van Laere S; Verhoef C; Hachem Y; Yumeen S; Meti N; Omeroglu A; Altinel G; Gao ZH; Yu ASL; Grünhagen DJ; Vermeulen P; Metrakos P; Siegel PM
Commun Biol; 2021 Jun; 4(1):657. PubMed ID: 34079064
[TBL] [Abstract][Full Text] [Related]
5. Sequential biphasic changes in claudin1 and claudin4 expression are correlated to colorectal cancer progression and liver metastasis.
Georges R; Bergmann F; Hamdi H; Zepp M; Eyol E; Hielscher T; Berger MR; Adwan H
J Cell Mol Med; 2012 Feb; 16(2):260-72. PubMed ID: 21388515
[TBL] [Abstract][Full Text] [Related]
6. Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences.
Kimbung S; Kovács A; Bendahl PO; Malmström P; Fernö M; Hatschek T; Hedenfalk I
Mol Oncol; 2014 Feb; 8(1):119-28. PubMed ID: 24287398
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of claudin-17 promotes a malignant phenotype in hepatocyte via Tyk2/Stat3 signaling and is associated with poor prognosis in patients with hepatocellular carcinoma.
Sun L; Feng L; Cui J
Diagn Pathol; 2018 Sep; 13(1):72. PubMed ID: 30219077
[TBL] [Abstract][Full Text] [Related]
8. Altered gene expression in breast cancer liver metastases.
Erin N; Wang N; Xin P; Bui V; Weisz J; Barkan GA; Zhao W; Shearer D; Clawson GA
Int J Cancer; 2009 Apr; 124(7):1503-16. PubMed ID: 19117052
[TBL] [Abstract][Full Text] [Related]
9. Autocrine CSF1R signaling mediates switching between invasion and proliferation downstream of TGFβ in claudin-low breast tumor cells.
Patsialou A; Wang Y; Pignatelli J; Chen X; Entenberg D; Oktay M; Condeelis JS
Oncogene; 2015 May; 34(21):2721-31. PubMed ID: 25088194
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of claudin expression changes in breast cancer with regional lymph node metastasis.
Szasz AM; Tokes AM; Micsinai M; Krenacs T; Jakab C; Lukacs L; Nemeth Z; Baranyai Z; Dede K; Madaras L; Kulka J
Clin Exp Metastasis; 2011 Jan; 28(1):55-63. PubMed ID: 20963473
[TBL] [Abstract][Full Text] [Related]
11. Claudin 1 in breast tumorigenesis: revelation of a possible novel "claudin high" subset of breast cancers.
Myal Y; Leygue E; Blanchard AA
J Biomed Biotechnol; 2010; 2010():956897. PubMed ID: 20490282
[TBL] [Abstract][Full Text] [Related]
12. [Claudins as prognostic factors of breast cancer].
Szász MA
Magy Onkol; 2012 Sep; 56(3):209-12. PubMed ID: 23139925
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-18 enhances breast cancer cell migration via down-regulation of claudin-12 and induction of the p38 MAPK pathway.
Yang Y; Cheon S; Jung MK; Song SB; Kim D; Kim HJ; Park H; Bang SI; Cho D
Biochem Biophys Res Commun; 2015 Apr; 459(3):379-86. PubMed ID: 25727011
[TBL] [Abstract][Full Text] [Related]
14. The role of lipolysis stimulated lipoprotein receptor in breast cancer and directing breast cancer cell behavior.
Reaves DK; Fagan-Solis KD; Dunphy K; Oliver SD; Scott DW; Fleming JM
PLoS One; 2014; 9(3):e91747. PubMed ID: 24637461
[TBL] [Abstract][Full Text] [Related]
15. A non-tight junction function of claudin-7-Interaction with integrin signaling in suppressing lung cancer cell proliferation and detachment.
Lu Z; Kim DH; Fan J; Lu Q; Verbanac K; Ding L; Renegar R; Chen YH
Mol Cancer; 2015 Jun; 14():120. PubMed ID: 26081244
[TBL] [Abstract][Full Text] [Related]
16. Tight Junction Protein Claudin-12 Is Involved in Cell Migration during Metastasis.
Kolchakova D; Moten D; Batsalova T; Dzhambazov B
Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33922921
[TBL] [Abstract][Full Text] [Related]
17. Afadin cooperates with Claudin-2 to promote breast cancer metastasis.
Tabariès S; McNulty A; Ouellet V; Annis MG; Dessureault M; Vinette M; Hachem Y; Lavoie B; Omeroglu A; Simon HG; Walsh LA; Kimbung S; Hedenfalk I; Siegel PM
Genes Dev; 2019 Feb; 33(3-4):180-193. PubMed ID: 30692208
[TBL] [Abstract][Full Text] [Related]
18. Claudin 2 deficiency reduces bile flow and increases susceptibility to cholesterol gallstone disease in mice.
Matsumoto K; Imasato M; Yamazaki Y; Tanaka H; Watanabe M; Eguchi H; Nagano H; Hikita H; Tatsumi T; Takehara T; Tamura A; Tsukita S
Gastroenterology; 2014 Nov; 147(5):1134-45.e10. PubMed ID: 25068494
[TBL] [Abstract][Full Text] [Related]
19. Oncostatin M induces upregulation of claudin-2 in rodent hepatocytes coinciding with changes in morphology and function of tight junctions.
Imamura M; Kojima T; Lan M; Son S; Murata M; Osanai M; Chiba H; Hirata K; Sawada N
Exp Cell Res; 2007 May; 313(9):1951-62. PubMed ID: 17434483
[TBL] [Abstract][Full Text] [Related]
20. Claudin-5 participates in the regulation of endothelial cell motility.
Escudero-Esparza A; Jiang WG; Martin TA
Mol Cell Biochem; 2012 Mar; 362(1-2):71-85. PubMed ID: 22038628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
